Late February, a study was released (http://nnw.fm/R2CEp) reviewing evidence that supports the use of cannabinoids to treat Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Also known as Lou Gehrig’s disease, ALS is a fatal illness that attacks the nerve cells that control voluntary muscles such as those in the face, arms, legs, and others.
Currently, ALS is treated with riluzole, a drug that controls neuronal signaling, but this drug does not cure the disease and can only slightly increase the chance of survival. With more effective therapeutic options needed to treat ALS, in-depth research has been done into the benefits of cannabinoids, the naturally occurring compounds found in the marijuana plant.
According to the article relating to the report, the cannabinoid system is involved in the pathology of ALS. A researcher shared that the data found proves that by editing CB2-mediated processes, it could change the progression of ALS and how much the endocannabinoid system could reduce excitotoxicity, neuroinflammation, and oxidative cell damage.
Testing on animals with ALS showed that cannabinoids have anti-inflammatory, antioxidant, and neuroprotective effects. It was also proven that cannabinoids can further delay the progression of the disease and prolong survival in these animals. Despite new cases of ALS being diagnosed each day, there are no obvious racial, ethnic, or socioeconomic boundaries associated with the disease.
With a shift in consumer, political, and legal views surrounding cannabis, as well as the current studies that are starting to show proof that CBD can help treat a variety of diseases, demand for CBD oil is on the rise across the globe. Companies such as ChineseInvestors.com (OTCQB: CIIX) are launching CBD health products in order to meet this growing demand.
Although China maintains its stance that cannabis is illegal both medically and recreationally, using CBD oil for medical purposes is allowed. As a result, ChineseInvestors.com is now launching the first CBD health products store in China and aims to be the first-ever provider of CBD oil products to customers in mainland China, and to Chinese speaking people in the United States and Canada.
The company aims to help people with diseases such as ALS by offering high-quality products that are both natural and legal, using compounds found in the cannabis plant that are not psychoactive. With the valid rationale to suggest the use of CBD to manage the symptoms of ALS, and the growing global need for high-quality CBD products, ChineseInvestors.com will be entering the market and helping treat numerous patients in two of the largest countries in the world.
For more information, visit the company’s website at www.ChineseInvestors.com
PsychedelicNewsWire (PNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. PNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled visibility, recognition and brand awareness. PNW is where news, content and information converge.
Please see full disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/disclaimer/